Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of clopidogrel and atorvastatin to inhibit cerebral emboli in dementia
2005-004283-23Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel and atorvastatin in Alzheimer's disease (AD) and vascular dementia, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Change in spontaneous cerebral emboli count. Started Nov 2005; status: completed.
02
Drugs
clopidogrelatorvastatin
03
Conditions
Alzheimer's disease (AD)vascular dementia
Beyond the preview
Go deeper on 2005-004283-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004283-23.